Neuroprotective effect of naringenin is mediated through suppression of NF-κB signaling pathway in experimental stroke

Neuroscience

Volumn 230, Issue , 2013, Pages 157-171

  Raza, S S ^a,c   Khan, M M ^a,d   Ahmad, A ^a,d   Ashafaq, M ^a   Islam, F ^a,b,e   Wagner, A P ^c   Safhi, M M ^b  

^a HAMDARD UNIVERSITY   (India)

^b JAZAN UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d UNIVERSITY OF IOWA   (United States)

^e HAMDARD UNIVERSITY   (India)

Author keywords

Cerebral ischemia; Naringenin; Neurobehavioral; Neuroinflammation; NF B; Oxidative stress

Indexed keywords

CYCLOOXYGENASE 2; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE; NARINGENIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; CELL ACTIVATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME ACTIVITY; GENE TARGETING; HISTOPATHOLOGY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTION; NONHUMAN; OPTIMAL DRUG DOSE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BRAIN INFARCTION; CYTOKINES; DISEASE MODELS, ANIMAL; FLAVANONES; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HAND STRENGTH; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPID PEROXIDATION; MALE; MOTOR ACTIVITY; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE; PEROXIDASE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; REPERFUSION; SIGNAL TRANSDUCTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84872332879     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.10.041     Document Type: Article

References (72)

1. Ahmad A., Khan M.M., Hoda M.N., Raza S.S., Khan M.B., Javed H., Ishrat T., Ashafaq M., Ahmad M.E., Safhi M.M., Islam F. Quercetin protects against oxidative stress associated damages in a rat model of transient focal cerebral ischemia and reperfusion. Neurochem Res 2011, 36:1360-1371.
2. Baluchnejadmojarad T., Roghani M. Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: a behavioral analysis. Pharmacology 2006, 78:193-197.
3. Barone F.C., Hillegass L.M., Price W.J., White R.F., Lee E.V., Feuerstein G.Z., Sarau H.M., Clark R.K., Griswold D.E. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res 1991, 29:336-345.
4. Berger R., Garnier Y., Jensen A. Perinatal brain damage: underlying mechanisms and neuroprotective strategies. J Soc Gynecol Investig 2002, 9:319-328.
5. Blondeau N., Widmann C., Lazdunski M., Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 2001, 21:4668-4677.
6. Botchkina G.I., Geimonen E., Bilof M.L., Villarreal O., Tracey K.J. Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity. Mol Med 1999, 5:372-381.
7. Bouet V., Freret T., Toutain J., Divoux D., Boulouard M. Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol 2007, 203:555-567.
8. Brambilla R., Bracchi-Ricard V., Hu W.H., Frydel B., Bramwell A., Karmally S., Green E.J., Bethea J.R. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 2005, 202:145-156.
9. Cavia-Saiz M., Busto M.D., Pilar-Izquierdo M.C., Ortega N., Perez-Mateos M. Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a comparative study. J Sci Food Agric 2010, 90:1238-1244.
10. Chao C.L., Weng C.S., Chang N.C., Lin J.S., Kao S.T. Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia. Nutr Res 2010, 30:858-864.
11. Clark R.K., Lee E.V., White R.F., Jonak Z.L., Feuerstein G.Z. Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull 1994, 35:387-392.
12. Clemens J.A., Stephenson D.T., Yin T., Smalstig E.B., Panetta J.A., Little S.P. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor kappa B in rats. Stroke 1998, 29:677-682.
13. Clemens J.A., Stephenson D.T., Dixon E.P., Smalstig E.B., Mincy R.E., Rash K.S. Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Mol Brain Res 1997, 48:187-196.
14. Denes A., Thornton P., Rothwell N.J., Allan S.M. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun 2009, 24:708-723.
15. Ding G.J., Fischer P.A., Boltz R.C., Schmidt J.A., Colaianne J.J., Gough A. Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. J Biol Chem 1998, 273:28897-28905.
16. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 2000, 62:649-671. (Review).
17. Gao D., Zhang X., Jiang X. Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci 2006, 78:2564-2570.
18. Gerhard A., Neumaier B., Elitok E., Glatting G., Ries V., Tomczak R., Ludolph A.C., Reske S.N. In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport 2000, 11:2957-2960.
19. Goldwasser J., Cohen P.Y., Yang E., Balaguer P., Yarmush M.L., Nahmias Y. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha. PLoS One 2010, 5:e12399.
20. Hamalainen M., Nieminen R., Vuorela P., Heinonen M., Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007, 2007:45673.
21. Heo H.J., Kim M.J., Lee J.M., Choi S.J., Cho H.Y., Hong B., Kim H.K., Kim E., Shin D.H. Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dement Geriatr Cogn Disord 2004, 17:151-157.
22. Hunter A.J., Mackay K.B., Rogers D.C. To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents. Trends Pharmacol Sci 1998, 19:59-66.
23. Jeong H.J., Choi I.Y., Kim M.H., Kim H.M., Moon P.D. Chungsim-Yeunja-Tang decreases the inflammatory response in peripheral blood mononuclear cells from patients with cerebral infarction through an NF-κB dependent mechanism. J Neuroinflamm 2010, 25:7-85.
24. Jiang S.X., Slinn J., Aylsworth A., Hou S.T. Vimentin participates in microglia activation and neurotoxicity in cerebral ischemia. J Neurochem 2012, 122:764-774.
25. Joshi C.N., Jain S.K., Murthy P.S. An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res Protoc 2004, 13:11-17.
26. Jollow D.J., Mitchell J.R., Zampaglione N. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974, 11:151-169.
27. Kanaze F.I., Bounartzi M.I., Georgarakis M., Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr 2007, 61:472-477.
28. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
29. Kannappan S., Anuradha C.V. Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome. Eur J Nutr 2010, 49:101-109.
30. Khan M.M., Gandhi C., Chauhan N., Stevens J.W., Motto D.G., Lentz S.R., Chauhan A.K. Alternatively-spliced extra domain a of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice. Stroke 2012, 43:1376-1382.
31. Khan M.M., Ahmad A., Ishrat T., Khuwaja G., Srivastava P., et al. Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res 2009, 1292:123-135.
32. Kumar A., Dogra S. Pathophysiology and therapeutic strategies in the management of stroke. Drugs Today 2008, 44:757-766.
33. Lapchak P.A. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator. Brain Res 2010, 1309:136-145.
34. Largo R., Alvarez-Soria M.A., I., Calvo E., Sánchez-Pernaute O., Egido J., Herrero-Beaumont G. Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2003, 11:290-298.
35. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
36. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-89.
37. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275.
38. Masuo Y., Matsumoto Y., Morita S., Noguchi J. A novel method for counting spontaneous motor activity in the rat. Brain Res 1997, 1:321-326.
39. Mattson M.P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001, 107:247-254.
40. McColl B.W., Allan S.M., Rothwell N.J. Systemic infection, inflammation and acute ischemic stroke. Neuroscience 2009, 158:1049-1061.
41. Moran P.M., Higgins L.S., Cordel B., Moser P.C. Age related learning deficits in transgenic mice expressing the 721-amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci U S A 1995, 92:5341-5345.
42. Olivier A.H., James K.L. NF-κB and innate immunity in ischemic stroke. Ann N Y Acad Sci 2010, 1207:32-40.
43. Ozbal S., Erbil G., Kocdor H., Tugyan K., Pekcetin C., Ozogul C. The effects of selenium against cerebral ischemia-reperfusion injury in rats. Neurosci Lett 2008, 438:265-269.
44. Park H.Y., Kim G.Y., Choi Y.H. Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases. Int J Mol Med 2012, 30:204-210.
45. Price C.J., Wang D., Menon D.K., Guadagno J.V., Cleij M., Fryer T., Aigbirhio F., Baron J.C., Warburton E.A. Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke 2006, 37:1749-1753.
46. Perez-Polo J.R., Reilly C.B., Rea H.C. Oxygen resuscitation after hypoxia ischemia stimulates prostaglandin pathway in rat cortex. Int J Dev Neurosci 2011, 29:639-644.
47. Raza S.S., Khan M.M., Ahmad A., Ashfaq M., Khuwaja G., Khan A., Tabassum R., Javed H., Siddiqui M.M., Safhi M.M., Islam F. Hesperidin improves functional and histological deficits and reduces neuroinflammation in ischemic brain injury in rats. Brain Res 2011, 28:93-105.
48. Rezaie P., Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002, 22:106-132.
49. Roghani M., Behzadi G. Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat, behavioral and histochemical evidence. Brain Res 2001, 892:211-217.
50. Rossi D.J., Brady J.D., Mohr C. Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 2007, 10:1377-1386.
51. Sabarinathan D., Mahalakshmi P., Vanisree A.J. Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats. Chem Biol Interact 2011, 15:26-36.
52. + (BKCa) channel opener in vascular smooth muscle cells. Br J Pharmacol 2006, 149:1013-1021.
53. Schallert T., Upchurch M., Lobaugh N., Farrar S.B., Spirduso W.W. Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostraital damage. Pharmacol Biochem Behav 1982, 16:455-462.
54. Sebban H., Courtois G. NF-kappaB and inflammation in genetic disease. Biochem Pharmacol 2006, 30:1153-1160.
55. Seegers H., Grillona E., Trioullierc Y.E., Albert V., Vernac J.M. Nuclear factor-kB activation in permanent intraluminal focal cerebral ischemia in the rat. Neurosci Lett 2000, 288:241-245.
56. Spilsbury A., Vauzour D., Spencer J.P., Rattray M. Regulation of NF-κB activity in astrocytes: effects of flavonoids at dietary-relevant concentrations. Biochem Biophys Res Commun 2012, 418:578-583.
57. Stevens M., Obrosova I., Cao X., Huysen C.V., Green D.A. Effects of d l-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy. Diabetes 2000, 49:1006-1015.
58. Sung B., Pandey M.K., Ahn K.S., Yi T., Chaturvedi M.M., Liu M., Aggarwal B.B. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 2008, 111:4880-4891.
59. Tu X.K., Yang W.Z., Shi S.S., Chen Y., Wang C.H., Chen C.M., Chen Z. Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia. Inflammation 2011, 34:463-470.
60. Tu X.K., Yang W.Z., Shi S.S., Wang C.H., Chen C.M. Neuroprotective effect of baicalin in a rat model of permanent focal cerebral ischemia. Neurochem Res 2009, 34:1626-1634.
61. Utley H.C., Bernheim F., Hochslein P. Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophys 1967, 260:521-531.
62. Vafeiadou K., Vauzour D., Lee H.Y., Rodriguez-Mateos A., Williams R.J. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 2009, 484:100-109.
63. Weston R.M., Jones N.M., Jarrott B., Callaway J. Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury. J Cereb Blood Flow Metab 2007, 27:100-114.
64. Wei Z., Chigurupati S., Arumugam T.V., Jo D.G., Li H., Chan S.L. Notch activation enhances the microglia-mediated inflammatory response associated with focal cerebral ischemia. Stroke 2011, 42:2589-2594.
65. Wang S., Wang H., Guo H., Kang L., Gao X., Hu L. Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation. Neuroscience 2011, 185:150-160.
66. Yang J., Li Q., Zhou X.D., Kolosov V.P., Perelman J.M. Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells. Mol Cell Biochem 2011, 351:29-40.
67. Yang L., Sameshima H., Yamaguchi M., Ikenoue T. Expression of inducible nitric oxide synthase and cyclooxygenase-2 mRNA in brain damage induced by lipopolysaccharide and intermittent hypoxia-ischemia in neonatal rats. J Obstet Gynaecol Res 2005, 31:185-191.
68. Yenari M.A., Xu L., Tang X.N., Qiao Y., Giffard R.G. Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 2006, 37:1087-1093.
69. Youdim K.A., Qaiser M.Z., Begley D.J., Rice-Evans C.A., Abbott N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004, 36:592-604.
70. Yousuf S, Atif F, Ahmad M, Ishrat T, Khan B (2010) Neuroprotection offered by Majun Khadar, a traditional unani medicine, during cerebral ischemic damage in rats. Evid Based Complement Altern Med 3.
71. Zbarsky V., Datla K.P., Parkar S., Rai D.K., Aruoma O.I., Dexter D.T. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 2005, 39:1119-1125.
72. Zhang X., Luhrs K.J., Ryff K.A., Malik W.T., Driscoll M.J., Culver B. Suppression of nuclear factor kappa B ameliorates astrogliosis but not amyloid burden in APPswe/PS1dE9 mice. Neuroscience 2009, 161:53-58.